Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease
Circulation: Cardiovascular Interventions · 2026-08 · 19 (8)
DOI: 10.1161/circinterventions.126.016735 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-08. Verfasst von Taito Arai und 43 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, Cardiovascular Research Foundation, New York, NY (T. Arai, K.I., H.Z., M.M., M.H., G.S.M., C.C.). Hauptthemen laut MEDLINE: Cardiac Catheterization, Coronary Angiography, Coronary Artery Disease, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Intravascular imaging (IVI) during percutaneous coronary intervention (PCI) improves outcomes. Pullback pressure gradient (PPG) characterizes coronary artery disease patterns as focal or diffuse; however, the benefit of IVI across this spectrum remains incompletely understood. We aimed to evaluate clinical outcomes after PCI with or without IVI guidance in patients with focal and diffuse disease defined by PPG. METHODS: Prospective, multicenter, single-arm study of 811 patients (840 vessels) undergoing PCI. PPG was calculated from manual fractional flow reserve pullbacks to define focal (PPG ≥0.62) or diffuse coronary artery disease. IVI use was at the operator’s discretion. The primary outcome was target vessel failure at 1-year follow-up. RESULTS: IVI-guided PCI was performed in 41% of patients. In the overall cohort, target vessel failure was lower with IVI guidance (adjusted hazard ratio, 0.60 [95% CI 0.36–0.99]; P =0.044), with a lower incidence of cardiac death ( P =0.042). IVI significantly reduced target vessel failure in focal disease (unadjusted HR, 0.41 [95% CI, 0.18–0.91]; P =0.029), whereas no difference was observed in diffuse disease (unadjusted HR, 0.91 [95% CI, 0.48–1.73]; P =0.771). There was no interaction between PPG and IVI guidance for target vessel failure ( P for interaction=0.128). CONCLUSIONS: In patients undergoing physiology-guided PCI, the use of IVI reduced clinical events at 1 year. These findings suggest that the benefit of IVI extends across the full spectrum of coronary artery disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Trial Center, Cardiovascular Research Foundation, New York, NY (T. Arai, K.I., H.Z., M.M., M.H., G.S.M., C.C.).
- Cardiovascular Center Aalst, Belgium (T. Arai, K.S., K.I., T.M., F.B., J.S., A.W., M.H., D.M., B.D.B., C.C.).
- Division of Cardiology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan (T. Arai, K.S., T.S.).
- Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Japan (K.I.).
- Division of Clinical Pharmacology, Department of Pharmacology, Showa University, Tokyo, Japan (T.M.).
- Department of Cardiology, Institute CARDIOMET, CHU-Toulouse, France (F.B.).
ORCID-Profile: Koshiro Sakai, Kazumasa Ikeda, Takuya Mizukami, Frédéric Bouisset, Mitsuaki Matsumura, Jeroen Sonck, Adriaan Wilgenhof, Hitoshi Matsuo, Tetsuya Amano, Hirohiko Ando, Masahiro Hada, Brian Ko, Simone Biscaglia, Fernando Rivero, Thomas Engstrøm, Lokien X van Nunen, William F Fearon, Evald Høj Christiansen, Stephane Fournier, Andy Yong, Julien Adjedj, Javier Escaned, Masafumi Nakayama, Ashkan Eftekhari, Danielle Keulards, Frederik M Zimmermann, Ethan Korngold, Daniel Munhoz, Gianluca Campo, Colin Berry, Damien Collison, Thomas W Johnson, Divaka Perera, Allen Jeremias, Ziad Ali, Bernard De Bruyne, Gary S Mintz, Nils Johnson, Toshiro Shinke, Carlos Collet
Zitieren
APA
Arai, T., Sakai, K., Ikeda, K., Mizukami, T., Bouisset, F., Zhang, H., Matsumura, M., Sonck, J., Wilgenhof, A., Matsuo, H., Amano, T., Ando, H., Hada, M., Ko, B., Biscaglia, S., Rivero, F., Engstrøm, T., Leone, A. M., van Nunen, L. X., …, & Collet, C. (2026). Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease. Circulation: Cardiovascular Interventions, 19(8). https://doi.org/10.1161/circinterventions.126.016735
Vancouver
Arai T, Sakai K, Ikeda K, Mizukami T, Bouisset F, Zhang H, et al. Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease. Circulation: Cardiovascular Interventions. 2026;19(8). doi:10.1161/circinterventions.126.016735
BibTeX
@article{Arai2026,
author = {Arai, Taito and Sakai, Koshiro and Ikeda, Kazumasa and Mizukami, Takuya and Bouisset, Frédéric and Zhang, Han and Matsumura, Mitsuaki and Sonck, Jeroen and Wilgenhof, Adriaan and Matsuo, Hitoshi and Amano, Tetsuya and Ando, Hirohiko and Hada, Masahiro and Ko, Brian and Biscaglia, Simone and Rivero, Fernando and Engstrøm, Thomas and Leone, Antonio Maria and van Nunen, Lokien X and Fearon, William F and Christiansen, Evald Høj and Fournier, Stephane and Desta, Liyew and Yong, Andy and Adjedj, Julien and Escaned, Javier and Nakayama, Masafumi and Eftekhari, Ashkan and Keulards, Danielle and Zimmermann, Frederik M and Korngold, Ethan and Munhoz, Daniel and Campo, Gianluca and Berry, Colin and Collison, Damien and Johnson, Thomas W and Perera, Divaka and Jeremias, Allen and Ali, Ziad and De Bruyne, Bernard and Mintz, Gary S and Johnson, Nils and Shinke, Toshiro and Collet, Carlos},
title = {Impact of Intravascular Imaging on Clinical Outcomes in Focal Versus Diffuse Coronary Artery Disease},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {8},
doi = {10.1161/circinterventions.126.016735}
}
EUVIMED